AQR Capital Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-47,245
| Closed | -$199K | – | 2365 |
|
|
2021
Q2 | $199K | Sell |
47,245
-23,994
| -34% | -$101K | ﹤0.01% | 2145 |
|
|
2021
Q1 | $355K | Buy |
+71,239
| New | +$355K | ﹤0.01% | 1958 |
|
|
2020
Q1 | – | Sell |
-13,648
| Closed | -$126K | – | 2189 |
|
|
2019
Q4 | $126K | Buy |
+13,648
| New | +$126K | ﹤0.01% | 2062 |
|
|
2019
Q2 | – | Sell |
-25,240
| Closed | -$305K | – | 2217 |
|
|
2019
Q1 | $305K | Sell |
25,240
-99,154
| -80% | -$1.2M | ﹤0.01% | 1964 |
|
|
2018
Q4 | $1.56M | Sell |
124,394
-119,687
| -49% | -$1.5M | ﹤0.01% | 1341 |
|
|
2018
Q3 | $3.62M | Sell |
244,081
-25,107
| -9% | -$373K | ﹤0.01% | 1136 |
|
|
2018
Q2 | $4.53M | Sell |
269,188
-118,560
| -31% | -$2M | ﹤0.01% | 1075 |
|
|
2018
Q1 | $8.88M | Buy |
387,748
+225,009
| +138% | +$5.15M | 0.01% | 804 |
|
|
2017
Q4 | $4.21M | Buy |
+162,739
| New | +$4.21M | ﹤0.01% | 1097 |
|
|
2016
Q4 | – | Sell |
-15,125
| Closed | -$153K | – | 2297 |
|
|
2016
Q3 | $153K | Sell |
15,125
-22,344
| -60% | -$226K | ﹤0.01% | 2194 |
|
|
2016
Q2 | $421K | Sell |
37,469
-29,317
| -44% | -$329K | ﹤0.01% | 1927 |
|
|
2016
Q1 | $912K | Sell |
66,786
-41,490
| -38% | -$567K | ﹤0.01% | 1611 |
|
|
2015
Q4 | $2.05M | Sell |
108,276
-49,805
| -32% | -$945K | ﹤0.01% | 1226 |
|
|
2015
Q3 | $2.97M | Buy |
158,081
+126,582
| +402% | +$2.38M | 0.01% | 972 |
|
|
2015
Q2 | $469K | Buy |
+31,499
| New | +$469K | ﹤0.01% | 1813 |
|